Supply Chain

Experts say the device's price surge is way out of step with production costs, and a needless drain on healthcare resources.

Optimizing value-based reimbursement and integration after a merger or acquisition also among top priorities.

From sample of 1,202 adults, eight percent of respondents said they or someone in their household had imported a drug at some point.

New coalition, health plans, employers and legislators will want greater assurances that PBMs are controlling costs, Moody says.

Standard form EHR contracts can be a bit tricky to negotiate, according to Office of the National Coordinator for Health Information Technology.

The first drug to treat Duchenne muscular dystrophy could sell for $350,000 a year.

HHS says at least 2 million people become infected with antibiotic-resistant bacteria, with 23,000 dying as a result.

Rising concerns about spending on prescription drugs that treat rare diseases are not justified, according to a new analysis in the journal Health Affairs.

As of July 1, the FDA had 4,036 generic drug applications awaiting approval; median time it takes for the FDA to approve a generic is now 47 months.

Integrated healthcare delivery and financing company UPMC is taking steps to thwart wasteful spending and high costs in forming an independent company called Pensiamo, which aims to help hospitals improve supply chain performance with a source-to-pay offering, including cognitive analytics with IBM Watson Health Technologies.